NFKB1 and liver cancer: A previous study has indicated that, co-delivery of DOX and pyrrolidine dithiocarbamate (PDTC, a NF-κB inhibitor) using chitosan-based nanoparticles can successfully reverse MDR of human liver cancer cells by PDTC-induced inactivation of NF-κB pathway 152.